Clinical Chemistry -- Table of Contents (July 2010, 56 [7])

Receive this page by email each issue: [Sign up for eTOCs]

Cover Image

Other Issues:

Contents:

July 2010, Volume 56, Issue 7
  [Index by Author]

       Editorials

       Perspective

       Q&A

       Clinical Case Study

       Clinical Chemistry Guide to Scientific Writing

       Review

       Opinion

       Evidence-Based Medicine and Test Utilization

       Molecular Diagnostics and Genetics

       Lipids, Lipoproteins, and Cardiovascular Risk Factors

       Endocrinology and Metabolism

       Cancer Diagnostics

       Proteomics and Protein Markers

       Brief Communications

       Citation Classics

       Letters to the Editor

       Clinical Chemist

Find articles in this issue containing these words: [Search ALL Issues]

Cover (PDF) | Table of Contents (PDF) | Editorial Board (PDF) | Advertising (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Editorials:

Paul M. Fernhoff: Duarte Galactosemia: How Sweet Is It?
Clinical Chemistry 2010 v. 56, p. 1045-1046. [Extract] [Full Text] [PDF]

Kristin M. Aakre and Sverre Sandberg: Can Changes in Troponin Results Be Useful in Diagnosing Myocardial Infarction?
Clinical Chemistry 2010 v. 56, p. 1047-1049. [Extract] [Full Text] [PDF]

Rong Mao and Lan-Szu Chou: Methylation Analysis by Restriction Endonuclease Digestion and Real-Time PCR
Clinical Chemistry 2010 v. 56, p. 1050-1052. [Extract] [Full Text] [PDF]

Perspective:

Sarah D. de Ferranti: Recovery from Metabolic Syndrome Is Both Possible and Beneficial
Clinical Chemistry 2010 v. 56, p. 1053-1055. [Extract] [Full Text] [PDF]

Q&A:

Mark A. Cervinski and Gregory J. Tsongalis: Direct-to-Consumer Genotyping: Are We Ready for a Brave New World?
Clinical Chemistry 2010 v. 56, p. 1056-1060. [Extract] [Full Text] [PDF]

Clinical Case Study:

Kamisha L. Johnson-Davis, Gwendolyn A. McMillin, JoEtta M. Juenke, Clyde D. Ford, and Finn B. Petersen: Which Dose of Busulfan Is Best?
Clinical Chemistry 2010 v. 56, p. 1061-1064. [Extract] [Full Text] [PDF] [Spanish Translation]

William Clarke: Commentary
Clinical Chemistry 2010 v. 56, p. 1064-1065. [Extract] [Full Text] [PDF]

Mark D. Kellogg: Commentary
Clinical Chemistry 2010 v. 56, p. 1065. [Extract] [Full Text] [PDF]

Clinical Chemistry Guide to Scientific Writing:

Thomas M. Annesley: Show Your Cards: The Results Section and the Poker Game
Clinical Chemistry 2010 v. 56, p. 1066-1070. [Extract] [Full Text] [PDF] [Spanish Translation]

Review:

Deborah Marsden and Harvey Levy: Newborn Screening of Lysosomal Storage Disorders
Clinical Chemistry 2010 v. 56, p. 1071-1079. [Abstract] [Full Text] [PDF]

Opinion:

David J. Glass: A Critique of the Hypothesis, and a Defense of the Question, as a Framework for Experimentation
Clinical Chemistry 2010 v. 56, p. 1080-1085. [Abstract] [Full Text] [PDF]

Evidence-Based Medicine and Test Utilization:

Vlad C. Vasile, Amy K. Saenger, Jean M. Kroning, and Allan S. Jaffe: Biological and Analytical Variability of a Novel High-Sensitivity Cardiac Troponin T Assay
Clinical Chemistry 2010 v. 56, p. 1086-1090. [Abstract] [Full Text] [PDF]

Brad S. Karon, James C. Boyd, and George G. Klee: Glucose Meter Performance Criteria for Tight Glycemic Control Estimated by Simulation Modeling
Clinical Chemistry 2010 v. 56, p. 1091-1097. [Abstract] [Full Text] [PDF]

Molecular Diagnostics and Genetics:

Thomas von Kanel, Dominik Gerber, André Schaller, Alessandra Baumer, Eva Wey, Christopher B. Jackson, Franziska M. Gisler, Karl Heinimann, and Sabina Gallati: Quantitative 1-Step DNA Methylation Analysis with Native Genomic DNA as Template
Clinical Chemistry 2010 v. 56, p. 1098-1106. [Abstract] [Full Text] [PDF]

Naïma Hanoun, Yannick Delpu, Arief A. Suriawinata, Barbara Bournet, Christophe Bureau, Janick Selves, Gregory J. Tsongalis, Marlène Dufresne, Louis Buscail, Pierre Cordelier, and Jérôme Torrisani: The Silencing of MicroRNA 148a Production by DNA Hypermethylation Is an Early Event in Pancreatic Carcinogenesis
Clinical Chemistry 2010 v. 56, p. 1107-1118. [Abstract] [Full Text] [PDF] [Supplemental Data]

David Dimmock, Lin-Ya Tang, Eric S. Schmitt, and Lee-Jun C. Wong: Quantitative Evaluation of the Mitochondrial DNA Depletion Syndrome
Clinical Chemistry 2010 v. 56, p. 1119-1127. [Abstract] [Full Text] [PDF] [Supplemental Data]

Lipids, Lipoproteins, and Cardiovascular Risk Factors:

Amar A. Sethi, Maureen Sampson, Russell Warnick, Nehemias Muniz, Boris Vaisman, Børge G. Nordestgaard, Anne Tybjærg-Hansen, and Alan T. Remaley: High Pre-β₁ HDL Concentrations and Low Lecithin: Cholesterol Acyltransferase Activities Are Strong Positive Risk Markers for Ischemic Heart Disease and Independent of HDL-Cholesterol
Clinical Chemistry 2010 v. 56, p. 1128-1137. [Abstract] [Full Text] [PDF] [Supplemental Data]

Endocrinology and Metabolism:

Mark M. Kushnir, Takara Blamires, Alan L. Rockwood, William L. Roberts, Bingfang Yue, Evrim Erdogan, Ashley M. Bunker, and A. Wayne Meikle: Liquid Chromatography–Tandem Mass Spectrometry Assay for Androstenedione, Dehydroepiandrosterone, and Testosterone with Pediatric and Adult Reference Intervals
Clinical Chemistry 2010 v. 56, p. 1138-1147. [Abstract] [Full Text] [PDF] [Supplemental Data]

Cancer Diagnostics:

Rafael Molina, Jose M. Auge, Blanca Farrus, Gabriel Zanón, Jaume Pahisa, Montserrat Muñoz, Aureli Torne, Xavier Filella, Jose M. Escudero, Pedro Fernandez, and Martin Velasco: Prospective Evaluation of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 15.3 (CA 15.3) in Patients with Primary Locoregional Breast Cancer
Clinical Chemistry 2010 v. 56, p. 1148-1157. [Abstract] [Full Text] [PDF]

Proteomics and Protein Markers:

Juha Lund, Saara Wittfooth, Qiu-Ping Qin, Tuomo Ilva, Pekka Porela, Kari Pulkki, Kim Pettersson, and Liisa-Maria Voipio-Pulkki: Free vs Total Pregnancy-Associated Plasma Protein A (PAPP-A) as a Predictor of 1-Year Outcome in Patients Presenting with Non–ST-Elevation Acute Coronary Syndrome
Clinical Chemistry 2010 v. 56, p. 1158-1165. [Abstract] [Full Text] [PDF]

Alexander G. Semenov, Natalia N. Tamm, Karina R. Seferian, Alexander B. Postnikov, Natalia S. Karpova, Daria V. Serebryanaya, Ekaterina V. Koshkina, Mihail I. Krasnoselsky, and Alexey G. Katrukha: Processing of Pro–B-Type Natriuretic Peptide: Furin and Corin as Candidate Convertases
Clinical Chemistry 2010 v. 56, p. 1166-1176. [Abstract] [Full Text] [PDF]

Brief Communications:

Can Ficicioglu, Christie Hussa, Paul R. Gallagher, Nina Thomas, and Claire Yager: Monitoring of Biochemical Status in Children with Duarte Galactosemia: Utility of Galactose, Galactitol, Galactonate, and Galactose 1-Phosphate
Clinical Chemistry 2010 v. 56, p. 1177-1182. [Abstract] [Full Text] [PDF]

Taichi Adachi, Michio Nakanishi, Yoritaka Otsuka, Kunihiro Nishimura, Gou Hirokawa, Yoichi Goto, Hiroshi Nonogi, and Naoharu Iwai: Plasma MicroRNA 499 as a Biomarker of Acute Myocardial Infarction
Clinical Chemistry 2010 v. 56, p. 1183-1185. [Abstract] [Full Text] [PDF] [Supplemental Data]

Citation Classics:

Paul M Ridker: Establishing a Clinical Basis for hsCRP in the Prevention and Treatment of Cardiovascular Disease
Clinical Chemistry 2010 v. 56, p. 1186-1187. [Extract] [Full Text] [PDF]

Letters to the Editor:

Corrie M. de Kat Angelino, Reinier Raymakers, Maria A. Teunesen, Joannes F.M. Jacobs, and Ina S. Klasen: Overestimation of Serum ${kappa}$ Free Light Chain Concentration by Immunonephelometry
Clinical Chemistry 2010 v. 56, p. 1188-1190. [Extract] [Full Text] [PDF]

Ken H. Darzy, Kashinath C. Dixit, Stephen M. Shalet, Nils G. Morgenthaler, and Georg Brabant: Circadian Secretion Pattern of Copeptin, the C-Terminal Vasopressin Precursor Fragment
Clinical Chemistry 2010 v. 56, p. 1190-1191. [Extract] [Full Text] [PDF]

Erna Lenters-Westra and Robbert J. Slingerland: Evaluation of the Quo-Test Hemoglobin A_1c Point-of-Care Instrument: Second Chance
Clinical Chemistry 2010 v. 56, p. 1191-1193. [Extract] [Full Text] [PDF]

George S. Cembrowski, David V. Tran, Linda Slater-MacLean, Dat Chin, R. T. Noel Gibney, and Michael Jacka: Could Susceptibility to Low Hematocrit Interference Have Compromised the Results of the NICE-SUGAR Trial?
Clinical Chemistry 2010 v. 56, p. 1193-1195. [Extract] [Full Text] [PDF]

Chris Florkowski, John Wallace, Trevor Walmsley, and Peter George: The Effect of Hemolysis on Current Troponin Assays—A Confounding Preanalytical Variable?
Clinical Chemistry 2010 v. 56, p. 1195-1197. [Extract] [Full Text] [PDF]

David C. Gaze and Paul O. Collinson: High-Sensitivity Cardiac Troponin: Seeing the Wood from the Trees
Clinical Chemistry 2010 v. 56, p. 1197-1198. [Extract] [Full Text] [PDF]

Tobias Reichlin, Raphael Twerenbold, and Christian Mueller: Comment on "High-Sensitivity Cardiac Troponin: Hype, Help, and Reality"
Clinical Chemistry 2010 v. 56, p. 1198-1199. [Extract] [Full Text] [PDF]

Allan S. Jaffe and Fred S. Apple: In Reply
Clinical Chemistry 2010 v. 56, p. 1199-1200. [Extract] [Full Text] [PDF]

Clinical Chemist:

: Lily Robinson and Ready, on the Set Go
Clinical Chemistry 2010 v. 56, p. 1201-1202. [Extract] [Full Text] [PDF]

Hoi-Ying Elsie Yu and Terence Law: What Is Your Guess? Unexpectedly High Thyroid-Stimulating Hormone—Another Case of Heterophile Antibody?
Clinical Chemistry 2010 v. 56, p. 1203-1204. [Extract] [Full Text] [PDF]

Lawrence Killingsworth: Unveiling the Right Side: Handcrafted Presentation Boxes Made of Exotic Woods
Clinical Chemistry 2010 v. 56, p. 1204-1205. [Extract] [Full Text] [PDF]